Home
About
Overview
Sharing Data
ORCID
Help
History (65)
Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program.
An updated approach to dysplasia in IBD.
Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.
Development of Luminescent Biosensors for Calprotectin.
See All 65 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of Luminescent Biosensors for Calprotectin.
Development of Luminescent Biosensors for Calprotectin. ACS Chem Biol. 2024 06 21; 19(6):1250-1259.
View in:
PubMed
subject areas
Biomarkers
Biosensing Techniques
Humans
Inflammatory Bowel Diseases
Leukocyte L1 Antigen Complex
Luciferases
Luminescence
Luminescent Measurements
Tuberculosis
authors with profiles
David Rubin
Shabaana Khader
Joel Pekow
Anthony Kossiakoff
Bryan Dickinson